Notice2021-24989
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 16, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 218 (Tuesday, November 16, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 218 (Tuesday, November 16, 2021)]
[Notices]
[Pages 63394-63395]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-24989]
[[Page 63394]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-1046]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled National Breast and Cervical Cancer Early
Detection Program (NBCCEDP) Monitoring Activities to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on July 26, 2021 to obtain comments from the
public and affected agencies. CDC received one non-substantive comment
related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Breast and Cervical Cancer Early Detection Program
(NBCCEDP) Monitoring Activities--(OMB Control No. 0920-1046, Exp. 11/
30/2021)--Revision--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC is requesting a Revision of the Information Collection Request
(ICR) titled National Breast and Cervical Cancer Early Detection
Program (NBCCEDP) Monitoring Activities (OMB Control No. 0920-1046). In
the previous OMB approval period, information collection consisted of
an annual NBCCEDP survey and clinic-level data collection. In the next
OMB approval period, information collection will consist of a revised
NBCCEDP survey, revised clinic-level data collection, new quarterly
program update, new service delivery projection worksheet, and the
addition of previously approved minimum data elements (MDEs; OMB
Control No. 0920-0571, Exp. 03/31/2022) to increase efficiency. The
number of respondents will remain the same and the total estimated
annualized burden will increase from 683 to 1,228.
Breast and cervical cancers are prevalent among U.S. women.
Evidence shows that deaths from both breast and cervical cancers can be
avoided by increasing screening services--mammography and pap tests--
among women. However, screening is typically underutilized among women
who are under- or uninsured, have no regular source of healthcare, or
who recently immigrated to the U.S. To improve access to cancer
screening, Congress passed the Breast and Cervical Cancer Mortality
Prevention Act of 1990 (Pub. L. 106-354) which directed CDC to create
the National Breast and Cervical Cancer Early Detection Program
(NBCCEDP). The NBCCEDP currently provides funding to 70 awardees under
``Cancer Prevention and Control Programs for State, Territorial, and
Tribal Organizations (DP17-1701).'' The purpose of NBCCEDP is to
increase breast and cervical cancer screening rates among women
residing within defined geographical locations (as determined by the
funded program) who are at or below 250% of the federal poverty level;
aged 40-64 years for breast cancer services, and aged 21-64 years for
cervical cancer services; and under- or uninsured.
In 2022, CDC will issue a new Notice of Funding Opportunity (DP22-
2202) to continue this mission. Consistent with programmatic changes,
the information collection plan has also been redesigned to update
existing and add new data collection instruments and integrate the
previously approved MDEs into this single approval package to increase
efficiency of information collection for the NBCCEDP.
CDC proposes five forms of information collection. First, the
NBCCEDP Survey will be submitted to CDC annually and collects
information to monitor awardees' TA needs, partnerships, screening
delivery, EBI implementation, and COVID-19 impact. Minor revisions to
survey questions, response options, and formatting will be included
under DP22-2202. Second, clinic-level data will be submitted to CDC at
baseline and annually for all partnering health system clinic sites--an
estimated six clinics per awardee for breast cancer data and six
clinics per awardee for cervical cancer data. Clinic-level data
includes health system, clinic, and patient population characteristics;
monitoring and quality improvement activities; EBI implementation;
COVID-19 impact, and baseline or annual screening rates. Minor
revisions were made to variable wording, formatting (e.g., split or
combined variables), and response options to improve data quality.
Third, the Quarterly Program Update (QPU) will be submitted to CDC four
times per year to monitor award spending, service delivery, staff
vacancies, and program accomplishments and challenges. This is a new
information collection. Fourth, the Service Delivery Projection
Worksheet will be submitted to CDC annually to report the estimated
number of women to be served for breast and cervical cancer. Finally,
the Minimum Data Elements (MDEs) will be submitted to CDC twice per
year to monitor patient demographics; breast and cervical cancer
screening, diagnosis, and treatment; timeliness of services; and
patient navigation. This information collection was previously approved
(OMB Control No. 0920-0571, Exp. 03/30/2022) and will now be
incorporated into this OMB approved package for increased efficiency
for NBCCEDP information collection efforts.
[[Page 63395]]
This revised information collection will allow CDC to provide
routine monitoring feedback to awardees based on their data
submissions, tailor technical assistance (TA) as needed, support
program planning, and assess program outcomes. OMB approval is
requested for three years. Participation is required for NBCCEDP
awardees. There are no costs to respondents other than their time. The
total estimated annual burden is 1,228 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hrs)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Awardees................... Annual NBCCEDP Survey...... 70 1 56/60
NBCCEDP Clinic-level 70 6 45/60
Information Collection
Instrument--Breast.
NBCCEDP Clinic-level 70 6 45/60
Information Collection
Instrument--Cervical.
Quarterly Program Update... 70 4 32/60
Service Delivery Projection 70 1 29/60
Worksheet.
MDEs....................... 70 2 150/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-24989 Filed 11-15-21; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on November 16, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.